Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
Background. Atherosclerotic cardiovascular disease (ASCVD) is a major cause of morbidity and mortality in patients with chronic kidney disease (CKD). In addition, CKD itself is a coronary artery disease equivalent due to its atherogenic potential. Despite the role of CKD in ASCVD and recommenda...
Saved in:
Main Authors: | M R Essop, F Seedat, F J Raal |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Medical Association
2023-11-01
|
Series: | South African Medical Journal |
Subjects: | |
Online Access: | https://samajournals.co.za/index.php/samj/article/view/1089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential management and associations of dyslipidaemia and hypertension by glycaemic status in urban South Africans
by: N Peer, et al.
Published: (2024-03-01) -
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
by: Katharine Barnard-Kelly, et al.
Published: (2025-02-01) -
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis
by: Lei Tian, et al.
Published: (2024-12-01) -
Prevalence of dyslipidaemia and transaminitis in obese 8 to 18-year-old in Eastern India
by: Ghose N, et al.
Published: (2024-10-01) -
Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review
by: Kisho Miyasako, et al.
Published: (2024-12-01)